Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 55 for “"GLP1"”.

  1. Οι επιδράσεις των αγωνιστών των υποδοχέων GLP1 και GLP1/GIP στη διαχείριση της παχυσαρκίας

    Η παχυσαρκία αποτελεί μία χρόνια, πολυπαραγοντική νόσο με συνεχώς αυξανόμενο επιπολασμό σε παγκόσμιο επίπεδο και συνδέεται με αυξημένο κίνδυνο εμφάνισης μεταβολικών, καρδιαγγειακών και άλλων χρόνιων νοσημάτων. Η παρούσα διπλωματική εργασία εξετάζει τον ρόλο των αγωνιστών των υποδοχέων GLP-1, …

    athens Repository record for Οι επιδράσεις των αγωνιστών των υποδοχέων GLP1 και GLP1/GIP στη διαχείριση της παχυσαρκίας (opens in a new tab)

  2. Glucose Homeostasis in Human Diabetic Adipocytes: Role of GLP1 in Sortilin Alternative Splicing

    … Incretin hormone glucagon-like peptide-1 (GLP1) is released in response to a meal and regulates glycemic control in a tissue specific manner. GLP1 is reduced in the serum of type 2 diabetic patients and is now widely used as a therapeutic to manage insulin resistance. Using human omental …

    usf Repository record for Glucose Homeostasis in Human Diabetic Adipocytes: Role of GLP1 in Sortilin Alternative Splicing (opens in a new tab)

  3. GLP1 – GIP και βαριατρικές επεμβάσεις. Σύγκριση στην απώλεια βάρους και στις μεταβολικές παραμέτρους

    … σε μεταβολική επέμβαση ή λάμβαναν τις ορμόνες GLP1 ή GLP1 – GIP. Αποκλείστηκαν μελέτες που αφορούσαν σε ανήλικους (ηλικία < 18 ετών), σε ζώα, ή σε ενήλικες με φυσιολογικό ΒΜΙ. Αποτελέσματα: Η χειρουργική παρέμβαση, ανεξαρτήτως της χρησιμοποιούμενης τεχνικής, υπερέχει της φαρμακευτικής με …

    athens Repository record for GLP1 – GIP και βαριατρικές επεμβάσεις. Σύγκριση στην απώλεια βάρους και στις μεταβολικές παραμέτρους (opens in a new tab)

  4. Untersuchung zum Mechanismus von SGLT2-Inhibitoren und GLP1-Rezeptoragonisten in zellulären Modellen von diabetischer Kardiomyopathie

    Mit SGLT2-Inhibitoren (SGLT2i) und GLP1-Rezeptor Agonisten (GLP1-RA) sind Arzneistoffe mit einem kardioprotektiven Effekt verfügbar, die zur Therapie von Patienten mit Typ-2-Diabetes und hohem kardiovaskulären Risiko empfohlen werden. Die Frage nach ihrem kardioprotektiven Wirkmechanismus, …

    qucosa-diss

  5. Novel Co-Treatment Strategies to Attenuate Acute Olanzapine-Induced Metabolic Dysfunction

    … novel pharmacological approaches with GLP1 and/or amylin analogs to offset the acute negative metabolic side effects of olanzapine.In study 1, it was found that co-treatment with glucagon-like peptide-1 (GLP1) receptor agonists protect against olanzapine-induced hyperglycemia and …

    guelph Repository record for Novel Co-Treatment Strategies to Attenuate Acute Olanzapine-Induced Metabolic Dysfunction (opens in a new tab)

  6. Efecto de los antidiabéticos análogos del receptor de GLP1 sobre la distensibilidad vascular y la enfermedad cardiovascular en sujetos diabéticos tipo 2

    … comportamiento de los análogos del receptor de GLP1 (arGLP1) en sujetos diabéticos tras cumplir doce meses de tratamiento sobre la distensibilidad vascular (medida por fotopletismografía digital) así como parámetros relacionados con el control metabólico. Comparar los resultados al final del …

    sevilla Repository record for Efecto de los antidiabéticos análogos del receptor de GLP1 sobre la distensibilidad vascular y la enfermedad cardiovascular en sujetos diabéticos tipo 2 (opens in a new tab)

  7. Caratterizzazione della funzione e del comportamento dell'alfa cellula pancreatica: analisi dei meccanismi fisiopatologici implicati nell'insorgenza del diabete

    … che le cellule alfa sono in grado di produrre GLP1 e che tale produzione di GLP1 è indotta dall'esposizione cronica al GLP1 stesso. Questo aspetto di notevole interesse per la patogenesi del diabete apre a nuovi spunti, la produzione a livello locale di GLP1 potrebbe servire all'isola per …

    catania Repository record for Caratterizzazione della funzione e del comportamento dell'alfa cellula pancreatica: analisi dei meccanismi fisiopatologici implicati nell'insorgenza del diabete (opens in a new tab)

  8. Development and validation of novel fluorescent probes to advance research into glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP1) receptor localisation and activity

    … agonising glucagon-like peptide-1 receptor (GLP1R) and dual agonists targeting GLP1R and glucose-dependent insulinotropic polypeptide receptor (GIPR) are revolutionising treatment for type 2 diabetes and obesity and showing promise in other conditions such as MASLD and IIH. Dual agonists …

    oxford Repository record for Development and validation of novel fluorescent probes to advance research into glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP1) receptor localisation and activity (opens in a new tab)

  9. Controlled Release Systems for Treating Type 2 Diabetes and Their Application Toward Multi-Agonist Combination Therapies

    … combining the incretin glucagon-like peptide-1 (GLP1) with FGF21, hypothesizing that this agent would merge the insulinotropic and anorectic effects of GLP1 with the enhanced insulin sensitivity and energy expenditure associated with FGF21 signaling. The dual agonist was designed as a single …

    duke Repository record for Controlled Release Systems for Treating Type 2 Diabetes and Their Application Toward Multi-Agonist Combination Therapies (opens in a new tab)

  10. Efeitos do tratamento com liraglutida na prevenção das alterações metabólicas induzidas pela castração em ratos machos e fêmeas

    … opções terapêuticas, está o uso de análogos do GLP1 (glucagon-like peptide 1). O GLP1 é um hormônio peptídico liberado principalmente pelas células L intestinais, ele estimula a secreção de insulina pelas células β e inibe a secreção de glucagon pelas células α, mantendo a homeostase da glicose. …

    brazil-ufrgs Repository record for Efeitos do tratamento com liraglutida na prevenção das alterações metabólicas induzidas pela castração em ratos machos e fêmeas (opens in a new tab)

  11. Sodium Glucose co-Transporter 2 (SGLT2) Inhibitors for Type 2 Diabetes Mellitus: Assessing their Safety and Effectiveness using Real-world Data

    … of fracture with SGLT2-inhibitors compared to GLP1 agonists; and (3) To identify predictors of SGLT2-related diabetic ketoacidosis using Machine Learning. Methods: All three studies utilized routinely collected data from large healthcare databases in the United States and applied the new-user …

    toronto-retro Repository record for Sodium Glucose co-Transporter 2 (SGLT2) Inhibitors for Type 2 Diabetes Mellitus: Assessing their Safety and Effectiveness using Real-world Data (opens in a new tab)

  12. Καρδιαγγειακά και νεφροπροστατευτικά οφέλη νεότερων αντιδιαβητικών φαρμάκων στην αντιμετώπιση του σακχαρώδη διαβήτη τύπου 2

    … αναστολείς) και οι αγωνιστές των υποδοχέων των GLP1. Σε μελέτες καρδιαγγειακής ασφάλειας, τα φάρμακα αυτά έχουν αποδεδειγμένο ευρύ φάσμα καρδιαγγειακών και νεφροπροστατευτικών πλεονεκτημάτων, μειώνοντας τα μείζονα καρδιαγγειακά συμβάματα και την καρδιαγγειακή θνητότητα σε ασθενείς με …

    athens Repository record for Καρδιαγγειακά και νεφροπροστατευτικά οφέλη νεότερων αντιδιαβητικών φαρμάκων στην αντιμετώπιση του σακχαρώδη διαβήτη τύπου 2 (opens in a new tab)

  13. Development and validation of a qPCR based high-throughput assay to quanti-tatively assess the productive uptake of peptide conjugated antisense oligonu-cleotides (ASO) in a GLP1 receptor over-expressing HEK293 cell line

    … up a two-step qPCR-based semi-automated assay on GLP1 receptor overexpressing HEK293 cell line and pri-mary mouse pancreatic islet cells to assess the delivery of a tool compound (ASO targeting MALAT1 ). The assay used in this study was based on another in-house assay, that involves cell lysis, …

    chalmers Repository record for Development and validation of a qPCR based high-throughput assay to quanti-tatively assess the productive uptake of peptide conjugated antisense oligonu-cleotides (ASO) in a GLP1 receptor over-expressing HEK293 cell line (opens in a new tab)

  14. Investigation of the molecular mechanisms underlying the invasive phenotype in a panel of lung cancer cell lines

    … a list of differentially expressed genes. GLP1R, KCNJ8 and TFPI2 genes were stably overexpressed and all induced invasion in non-invasive DLKP 17. Furthermore GLP1-R induced invasion could be reversed through siRNA induced silencing of the transgene. GLP1-R overexpression in non-invasive …

    dcu Download PDF for Investigation of the molecular mechanisms underlying the invasive phenotype in a panel of lung cancer cell lines (opens in a new tab)

  15. Analyses of histone modifications - H1.2K187 methylation and H3K64 methylation

    … as a new methylation site methylated by G9a/Glp1 using a candidate approach. In order to map the site, a cluster mutation approach was developed, providing a new method for (histone) modification analysis, and used in combination with protease digestion. The site was confirmed by in vitro …

    freiburg-diss Repository record for Analyses of histone modifications - H1.2K187 methylation and H3K64 methylation (opens in a new tab)

  16. Μελέτη των ορμονικών μεταβολών του πεπτικού συστήματος μετά από λαπαροσκοπική επιμήκη γαστρεκτομή για την θεραπεία της νοσογόνου παχυσαρκίας

    … της Γκρελίνης, Ινσουλίνης, Αμυλίνης, PP, PYY, GLP1, καθώς και τηςΛεπτίνης.ΜέθοδολογίαΑσθενείς15 ασθενείς υπεβλήθησαν σε Λαπαροσκοπική Επιμήκη Γαστρεκτομή (LSG).Προεγχειρητικά και μετεγχειρητικά στον 6ο και 12ο μήνα, έγινε συλλογή δειγμάτωναίματος, μετά από 12ωρη νηστεία και στα 60 και 120 λεπτά …

    greece Repository record for Μελέτη των ορμονικών μεταβολών του πεπτικού συστήματος μετά από λαπαροσκοπική επιμήκη γαστρεκτομή για την θεραπεία της νοσογόνου παχυσαρκίας (opens in a new tab)

  17. Impacto pronóstico de la resistencia a la insulina en pacientes con ictus isquémico tratados con tratamiento trombolitico endovenoso : estudio clínico y de biomarcadores

    … 11 citokinas(Péptido-C, Grelina, GIP, GLP1, Glucagón, Insulina, Leptina, Resistina, Visfatina, IL6 y TNFα)en 3 tiempos: pre-tPA, post-tPA y 24h. Variables pronósticas: buen pronóstico-3mes, mejoría neurológica<24h, recanalización arterial, volumen infarto y transformación hemorrágica. …

    valladolid Repository record for Impacto pronóstico de la resistencia a la insulina en pacientes con ictus isquémico tratados con tratamiento trombolitico endovenoso : estudio clínico y de biomarcadores (opens in a new tab)

  18. Benefits of SGLT2 inhibitor and GLP-1 receptor agonist therapies in patients with chronic kidney disease

    … και διαβήτη τύπου 2, οι αγωνιστές των υποδοχέων GLP1 σχετίζονται με νεφρικό όφελος, κυρίως για τη μείωση της λευκωματουρίας και την καθυστέρηση της πτώσης της κλίσης του eGFR. Η συνδυαστική θεραπεία θεωρείται η καλύτερη θεραπευτική επιλογή στους περισσότερους ασθενείς με ΧΝΝ.

    athens Repository record for Benefits of SGLT2 inhibitor and GLP-1 receptor agonist therapies in patients with chronic kidney disease (opens in a new tab)

Page 1 of 3